Blog
RSS FeedPosted by Michael Wonder on 14 Apr 2020
LifeMax receives fast track designation for LM-030 for the treatment of Netherton syndrome
14 April 2020 - LifeMax Laboratories today announced that the FDA granted fast track designation to LM-030, an investigational therapy licensed ...
Posted by Michael Wonder on 14 Apr 2020
Drug evaluation during the COVID-19 pandemic
14 April 2020 - The search for a treatment for COVID-19 is testing our country’s ability to quickly develop, test, ...
Posted by Michael Wonder on 14 Apr 2020
Alnylam receives fast track designation for vutrisiran for the treatment of the polyneuropathy of hATTR amyloidosis
14 April 2020 - Alnylam Pharmaceuticals announced today that the U.S. FDA has granted fast track designation to vutrisiran, an ...
Posted by Michael Wonder on 14 Apr 2020
Vaccine development is a case of 'market failure'
13 April 2020 - Reliance on the private market to develop vaccines has failed, leaving us vulnerable to pandemics such as ...
Posted by Michael Wonder on 14 Apr 2020
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
13 April 2020 - The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 ...
Posted by Michael Wonder on 14 Apr 2020
Why a decades old TB vaccine is getting attention in the fight against COVID-19
14 April 2020 - In the desperate search for ammunition to fend off the COVID-19 pandemic, a decades old tuberculosis ...
Posted by Michael Wonder on 14 Apr 2020
Regulators split on anti-malarials for COVID-19
11 April 2020 - US and French authorities have authorised the use of chloroquine and hydroxychloroquine, but the EU regulator and ...
Posted by Michael Wonder on 14 Apr 2020
COVID-19: Ebola drug leads treatment race
13 April 2020 - A failed Ebola drug is emerging as the treatment of choice for COVID-19 after Australian scientists ...
Posted by Michael Wonder on 14 Apr 2020
Potential coronavirus drugs may cost as little as $1, study says
10 April 2020 - Treatments being studied sell for hundreds of times their cost. ...
Posted by Michael Wonder on 14 Apr 2020
Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs
13 April 2020 - In July 2018, the FDA first published a table listing all surrogate measures that it has used, ...
Posted by Michael Wonder on 14 Apr 2020
COVID-19: world needs a global approach to fight: Bill Gates
12 April 2020 - Over the past few weeks, I’ve spoken to dozens of experts about COVID-19, and there’s clear ...
Posted by Michael Wonder on 13 Apr 2020
Gilead Canada submits supplemental new drug submission to Health Canada for Descovy for HIV pre-exposure prophylaxis
9 April 2020 - Submission supported by data from the DISCOVER trial, which evaluated the safety and efficacy of Descovy compared ...
Posted by Michael Wonder on 13 Apr 2020
Fennec Pharmaceuticals announces FDA filing acceptance and priority review of new drug application for Pedmark
13 April 2020 - FDA grants priority review and sets a Prescription Drug User Fee Act target action date of 10 ...
Posted by Michael Wonder on 13 Apr 2020
How a premier U.S. drug company became a virus ‘super spreader'
12 April 2020 - Biogen employees unwittingly spread the coronavirus from Massachusetts to Indiana, Tennessee and North Carolina. ...
Posted by Michael Wonder on 13 Apr 2020
COVID-19: Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries
10 April 2020 - The company already increased its production capacity by 50% and is on track to further increase production ...